시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 핵의학 이미징 장비 시장 분석과 예측(-2034년) : 유형, 제품, 서비스, 기술, 용도, 최종 사용자, 컴포넌트, 기능, 설치 유형, 솔루션
Nuclear Imaging Equipment Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Application, End User, Component, Functionality, Installation Type, Solutions
상품코드 : 1699143
리서치사 : Global Insight Services LLC
발행일 : 2025년 04월
페이지 정보 : 영문 438 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,750 ￦ 6,666,000
Single User License help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능하며, 인쇄는 가능합니다.
US $ 5,750 ￦ 8,069,000
Site License help
PDF, Excel 보고서를 동일 기업(국가)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,750 ￦ 9,472,000
Enterprise License help
PDF, Excel 보고서를 동일 기업의 전 세계 모든분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

세계의 핵의학 이미징 장비 시장은 2024년 31억 1,000만 달러에서 2034년까지 53억 2,000만 달러로 확대되어 CAGR 약 5.5%를 보일 것으로 예측됩니다. 이 분야에는 감마 카메라, PET 스캐너, SPECT 시스템 등이 포함되어 종양학, 심장 병학, 신경학의 진단에 필수적입니다. 이미징 기술의 진보, 인구의 고령화, 만성 질환의 유병률의 상승에 견인되어, 동 시장은 성장 태세에 있습니다 이미징 처리 기능의 끊임없는 혁신과 헬스케어 투자 증가가 시장의 가능성을 더? 높이고 있습니다.

시장 개요:

핵의학 이미징 장비 시장은 진단센터, 병원, 연구 기관으로 구분되며, 병원은 광범위한 인프라와 높은 도입률로 시장을 선도하고 있습니다. 병원은 진단 정확성과 환자 결과를 향상시키기 위해 첨단 핵 이미징 기술을 통합하고 만성 질환의 유병률을 높이고 정밀 진단 도구에 대한 수요를 뒷받침하기 때문에 병원이 우위를 차지합니다. PET와 CT 또는 MRI를 결합한 하이브리드 이미징 시스템과 같은 기술 진보는 종합적인 진단 기능을 제공함으로써 우위를 강화하고 있습니다. 새로운 하위 부문은 휴대용 핵의학 이미징 장비를 포함하고 있으며, 특히 원격지나 의료가 잘 되지 않는 지역에서 POC(Point of Care) 진단에 혁명을 일으킬 수 있기 때문에 견인력을 증가시키고 있습니다. 개인화된 의료에 대한 관심 증가는 진단 정확도의 향상과 치료 모니터링의 잠재력을 갖춘 특수 영상 진단제의 개발을 뒷받침하고 있습니다. 이러한 하위 부문이 진화함에 따라 접근성의 확대와 진단 효율의 향상은 시장의 역학에 큰 영향을 미칠 것으로 보입니다.

시장 세분화
유형 SPECT 이미징, PET 이미징, 평면 신티그래피
제품 감마 카메라, PET 스캐너, SPECT-CT, PET-CT
서비스 설치, 유지 보수, 교육, 컨설테이션
기술 하이브리드 이미징, 독립형 이미징
용도 심장병학, 종양학, 신경학, 정형외과
최종 사용자 병원, 진단센터, 조사 기관, 외래수술센터(ASC)
구성요소 검출기, 컴퓨터, 소프트웨어, 시준기
기능 진단 이미징, 치료 이미징
설치 유형 고정식, 이동식
솔루션 이미지 분석 소프트웨어, 데이터 관리 시스템

핵 의학 이미징 장비 시장에서 단일 광자 방출 컴퓨터 단층 촬영(SPECT) 시스템은 최대 시장 점유율을 차지하고 양전자 방출 단층 촬영(PET) 시스템과 하이브리드 이미징 솔루션이 약간 차이가 있습니다. Siemens Healthineers, GE Healthcare, Philips Healthcare와 같은 주요 기업들은 혁신과 전략적 제휴를 통해 적극적으로 포트폴리오를 강화하고 있습니다. 앞으로의 전망은 낙관적이며 분자 이미징과 맞춤형 의료의 진보가 시장 성장을 가속할 것으로 예측됩니다.

주요 동향과 촉진요인:

핵의학 이미징 장비 시장은 기술의 진보와 만성 질환의 만연 증가에 의해 강력한 성장을 이루고 있습니다. PET-CT나 SPECT-CT 등 복수의 모달리티를 결합하고 종합적인 진단 인사이트를 제공하는 하이브리드 영상 진단 시스템에 대한 선호도가 높아지고 있습니다. 노년인구 증가가 이미징 진단 수요 증가에 기여하고 있으며, 진보된 장비가 필요합니다. 기술 혁신과 전략적 파트너십에 중점을 둔 기업은 이러한 동향을 활용하는데 유리한 입장에 있습니다.

억제요인과 도전:

핵의학 이미징 장비 시장은 몇 가지 심각한 억제요인과 문제에 직면하고 있습니다. 또한, 핵의학 이미징 장비의 승인과 사용에 대한 규제 요건이 엄격하기 때문에 신제품 시장 진입이 지연될 수 있습니다. 또한 이러한 기술의 효율성과 효과에 영향을 미칩니다. 또한 방사선 노출과 관련 건강 위험에 대한 우려가 환자와 건강 관리 제공업체의 망설임으로 이어질 수 있습니다. 나중에, 핵의학 이미징 장비의 높은 보수 및 운용 비용이 의료기관의 재정 부담이 되어, 시장의 성장을 한층 더 억제할 가능성이 있습니다.

목차

제1장 핵의학 이미징 장비 시장 개요

제2장 주요 요약

제3장 시장에 관한 중요 인사이트

제4장 핵의학 이미징 장비 시장 전망

제5장 핵의학 이미징 장비 시장 전략

제6장 핵의학 이미징 장비 시장 규모

제7장 핵의학 이미징 장비 시장 : 유형별

제8장 핵의학 이미징 장비 시장 : 제품별

제9장 핵의학 이미징 장비 시장 : 서비스별

제10장 핵의학 이미징 장비 시장 : 기술별

제11장 핵의학 이미징 장비 시장 : 용도별

제12장 핵의학 이미징 장비 시장 : 최종 사용자별

제13장 핵의학 이미징 장비 시장 : 컴포넌트별

제14장 핵의학 이미징 장비 시장 : 기능별

제15장 핵의학 이미징 장비 시장 : 설치 유형별

제16장 핵의학 이미징 장비 시장 : 솔루션별

제17장 핵의학 이미징 장비 시장 : 지역별

제18장 경쟁 구도

제19장 기업 프로파일

JHS
영문 목차

영문목차

Nuclear Imaging Equipment Market is anticipated to expand from $3.11 billion in 2024 to $5.32 billion by 2034, growing at a CAGR of approximately 5.5%. The market encompasses devices used for medical imaging techniques that utilize radioactive substances to visualize and diagnose conditions within the body. This sector includes gamma cameras, PET scanners, and SPECT systems, which are integral in oncology, cardiology, and neurology diagnostics. Driven by advancements in imaging technology, an aging population, and rising prevalence of chronic diseases, the market is poised for growth. Continuous innovation in imaging capabilities and increasing healthcare investments further enhance market potential.

Market Overview:

The Nuclear Imaging Equipment Market is segmented into diagnostic centers, hospitals, and research institutes, with hospitals leading the charge due to their expansive infrastructure and higher adoption rates. Hospitals dominate as they integrate advanced nuclear imaging technologies to enhance diagnostic accuracy and patient outcomes, driven by the rising prevalence of chronic diseases and the demand for precise diagnostic tools. Technological advancements such as hybrid imaging systems, which combine PET and CT or MRI, bolster their dominance by offering comprehensive diagnostic capabilities. Emerging sub-segments include portable nuclear imaging devices, gaining traction due to their potential to revolutionize point-of-care diagnostics, especially in remote or underserved regions. The growing interest in personalized medicine further propels the development of specialized imaging agents, promising to refine diagnostic precision and therapeutic monitoring. As these sub-segments evolve, they are poised to significantly impact market dynamics by expanding accessibility and improving diagnostic efficiency.

Market Segmentation
TypeSPECT Imaging, PET Imaging, Planar Scintigraphy
ProductGamma Cameras, PET Scanners, SPECT-CT, PET-CT
ServicesInstallation, Maintenance, Training, Consultation
TechnologyHybrid Imaging, Standalone Imaging
ApplicationCardiology, Oncology, Neurology, Orthopedics
End UserHospitals, Diagnostic Centers, Research Institutes, Ambulatory Surgical Centers
ComponentDetectors, Computers, Software, Collimators
FunctionalityDiagnostic Imaging, Therapeutic Imaging
Installation TypeFixed, Mobile
SolutionsImage Analysis Software, Data Management Systems

In the Nuclear Imaging Equipment Market, single-photon emission computed tomography (SPECT) systems hold the largest market share, closely followed by positron emission tomography (PET) systems and hybrid imaging solutions. This distribution is fueled by the growing prevalence of chronic diseases and the increasing demand for accurate diagnostic tools. North America remains at the forefront of adoption, while the Asia-Pacific region is witnessing significant investment and technological advancements. Key industry players, including Siemens Healthineers, GE Healthcare, and Philips Healthcare, are actively enhancing their portfolios through innovation and strategic partnerships. Regulatory frameworks in North America and Europe play a pivotal role in shaping market dynamics, impacting both compliance and innovation. The future outlook is optimistic, with advancements in molecular imaging and personalized medicine expected to propel market growth. Challenges such as high equipment costs and stringent regulatory requirements persist, yet ongoing research and development efforts promise to unlock new opportunities and drive technological progress.

Geographical Overview:

The nuclear imaging equipment market showcases varied growth patterns across different regions, each exhibiting unique characteristics. North America stands at the forefront, driven by advanced healthcare infrastructure and significant investments in nuclear imaging technologies. The presence of leading industry players and ongoing research initiatives further bolster the market's expansion. Europe follows closely, with a strong focus on innovation and the integration of nuclear imaging in diagnostic procedures. The region's stringent regulatory framework ensures high standards, fostering trust and adoption. In the Asia Pacific, the market is witnessing rapid growth, propelled by increasing healthcare expenditure and a rising prevalence of chronic diseases. The region's burgeoning middle class and improving healthcare access contribute to the demand for nuclear imaging solutions. Latin America presents promising opportunities, with growing awareness and investments in healthcare infrastructure. The region's efforts to enhance diagnostic capabilities drive market growth. The Middle East & Africa, while still emerging, display significant potential due to rising healthcare investments and government initiatives aimed at improving medical facilities. The adoption of nuclear imaging equipment in these regions is expected to rise, driven by a focus on early disease detection and advanced diagnostic capabilities.

Recent Development:

The Nuclear Imaging Equipment Market has experienced noteworthy developments in recent months, reflecting the dynamic nature of this sector. Siemens Healthineers announced a strategic acquisition of a leading nuclear imaging software firm, aiming to enhance its diagnostic capabilities and expand its product portfolio. GE Healthcare unveiled a new state-of-the-art PET/CT scanner, promising improved image quality and reduced scan times, which is expected to set new industry standards. Philips entered into a collaboration with a prominent academic institution to advance nuclear imaging research, focusing on innovative imaging technologies to improve patient outcomes. Canon Medical Systems reported a significant investment in expanding its manufacturing facilities in Japan, aimed at meeting the growing global demand for advanced nuclear imaging equipment. In regulatory developments, the FDA approved a groundbreaking radiopharmaceutical agent, which is anticipated to enhance the accuracy of nuclear imaging diagnostics, offering new opportunities for early disease detection and personalized treatment plans. These events underscore the sector's commitment to innovation and growth.

Key Trends and Drivers:

The Nuclear Imaging Equipment Market is experiencing robust growth driven by technological advancements and an increasing prevalence of chronic diseases. Key trends include the integration of artificial intelligence to enhance imaging accuracy and diagnostic efficiency. This innovation is streamlining workflows and improving patient outcomes. Additionally, there is a growing preference for hybrid imaging systems that combine multiple modalities, such as PET/CT and SPECT/CT, providing comprehensive diagnostic insights. The rising adoption of nuclear imaging in oncology, cardiology, and neurology is a significant driver, as these areas benefit from precise imaging capabilities. Moreover, the expanding geriatric population is contributing to higher demand for diagnostic imaging, necessitating advanced equipment. Governments and healthcare institutions are investing in modernizing healthcare infrastructure, further propelling market growth. Opportunities abound in emerging markets where healthcare spending is on the rise, and access to advanced diagnostic tools is expanding. Furthermore, the development of novel radiopharmaceuticals is enhancing the scope of nuclear imaging applications, offering new avenues for market expansion. Companies that focus on innovation and strategic partnerships are well-positioned to capitalize on these trends. The emphasis on early disease detection and personalized medicine is expected to sustain the market's upward trajectory, making it a lucrative sector for investment and development.

Restraints and Challenges:

The nuclear imaging equipment market is confronted with several significant restraints and challenges. A primary challenge is the high cost associated with nuclear imaging equipment, which can deter smaller healthcare facilities from adopting these technologies. Additionally, stringent regulatory requirements for approval and usage of nuclear imaging devices can delay market entry for new products. There is also a shortage of skilled professionals capable of operating advanced nuclear imaging equipment, impacting the efficiency and effectiveness of these technologies. Furthermore, concerns about radiation exposure and associated health risks may lead to hesitancy among patients and healthcare providers, limiting the utilization of these systems. Lastly, the high maintenance and operational costs of nuclear imaging equipment can pose financial burdens on healthcare institutions, further constraining market growth. These challenges collectively create obstacles for the widespread adoption and expansion of nuclear imaging technologies.

Key Companies:

Digirad, Neusoft Medical Systems, Surgic Eye, Mediso Medical Imaging Systems, DDD- Diagnostic, Spectrum Dynamics Medical, Sofie Biosciences, Gamma Medica, CMR Naviscan, Biosensors International, Trivitron Healthcare, Curium, Nuclear Imaging Services, Eckert & Ziegler, Blue Earth Diagnostics, Shenzhen Anke High- Tech, Shenzhen Mindray Bio- Medical Electronics, Shenzhen Basda Medical Apparatus, United Imaging Healthcare, Ziehm Imaging

Sources:

World Health Organization (WHO), International Atomic Energy Agency (IAEA), U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), National Institutes of Health (NIH), Radiological Society of North America (RSNA), Society of Nuclear Medicine and Molecular Imaging (SNMMI), European Association of Nuclear Medicine (EANM), American College of Radiology (ACR), International Society for Magnetic Resonance in Medicine (ISMRM), National Cancer Institute (NCI), The Royal College of Radiologists (RCR), International Conference on Nuclear Cardiology and Cardiac CT (ICNC), European Congress of Radiology (ECR), The American Association of Physicists in Medicine (AAPM), Health Canada, National Institute for Health and Care Excellence (NICE), The European Society for Radiotherapy and Oncology (ESTRO), World Molecular Imaging Congress (WMIC), The American Society of Nuclear Cardiology (ASNC)

Research Scope:

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Nuclear Imaging Equipment Market Overview

2: Executive Summary

3: Premium Insights on the Market

4: Nuclear Imaging Equipment Market Outlook

5: Nuclear Imaging Equipment Market Strategy

6: Nuclear Imaging Equipment Market Size

7: Nuclear Imaging Equipment Market, by Type

8: Nuclear Imaging Equipment Market, by Product

9: Nuclear Imaging Equipment Market, by Services

10: Nuclear Imaging Equipment Market, by Technology

11: Nuclear Imaging Equipment Market, by Application

12: Nuclear Imaging Equipment Market, by End User

13: Nuclear Imaging Equipment Market, by Component

14: Nuclear Imaging Equipment Market, by Functionality

15: Nuclear Imaging Equipment Market, by Installation Type

16: Nuclear Imaging Equipment Market, by Solutions

17: Nuclear Imaging Equipment Market, by Region

18: Competitive Landscape

19: Company Profiles

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기